Seller record · Telehealth service

Lovely Meds

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S5, analytical documentation: No certificate of analysis or lot document is published. The product pages describe pH, potency, endotoxin and sterility checks on each batch with no document behind the claim. 1 more criterion also fails; see the table below.

At a glance

Lovely MedsTelehealth service

6/8criteria passed

Price: Semaglutide $39 the first month, then from $99 a month; tirzepatide $90, then from $150
Sells: compounded semaglutide injection kit (with B12), and 26 more
FDA letters: 1 on file

Visit Lovely Meds See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A telehealth platform selling compounded semaglutide and tirzepatide injections with B12, oral drops, dissolving tablets and troches, brand-name GLP-1 drugs, and sermorelin, NAD+, glutathione and copper peptide products. Care starts with an online health form, seven dispensing pharmacies are named, and it prints two different company addresses.

Operating entity Lovely Meds, Inc.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Lovely Meds' FAQ; Lovely Meds' regulations page; Lovely Meds' terms and conditions
S2	Prescription gating	PASS	Lovely Meds' how it works page; Lovely Meds' FAQ; Lovely Meds' terms and conditions
S3	Pharmacy identification	PASS	Lovely Meds' regulations page
S4	Compounding disclosure	PASS	Lovely Meds' website; Lovely Meds' compounded semaglutide page; Lovely Meds' semaglutide troche page; Lovely Meds' FAQ
S5	Analytical documentation	FAIL	Lovely Meds' compounded semaglutide page; Lovely Meds' NAD+ page
S6	Business address	FAIL	Lovely Meds' regulations page; Lovely Meds' privacy policy; Lovely Meds' terms and conditions
S7	Price disclosure	PASS	Lovely Meds' compounded semaglutide page; Lovely Meds' compounded tirzepatide page; Lovely Meds' semaglutide page; Lovely Meds' tirzepatide page; Lovely Meds' oral semaglutide page; Lovely Meds' NAD+ page; Lovely Meds' compounded sermorelin page; Lovely Meds' sermorelin nasal spray page
S8	Enforcement status	PASS	FDA's website; FDA warning letter 716829

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed clinician reviews each health intake and prescribes only if treatment is appropriate. The regulations page says clinical care is given by professionals affiliated with Wasef Health, P.C., under the medical direction of Michael Wasef, MD, while the terms name Beluga Health, P.A. as the providers' group.Source: Lovely Meds' FAQ; Lovely Meds' regulations page; Lovely Meds' terms and conditions.

S2PASSThe start buttons open an online visit, and the how it works page puts a confidential health form first, followed by a specialist's review of the buyer's health information. The answers say a licensed clinician reviews the intake before any prescription, and the terms say orders are reviewed by a prescriber before final approval.Source: Lovely Meds' how it works page; Lovely Meds' FAQ; Lovely Meds' terms and conditions.

S3PASSThe regulations page names seven independent dispensing pharmacies with addresses: The Pharmacy Hub in Miami, Florida, Hallandale Pharmacy in Fort Lauderdale, Florida, Vials RX and Greenwich RX in Tomball, Texas, Strive Pharmacy in Gilbert, Arizona, Partell Specialty Pharmacy in Las Vegas, Nevada, and HealthWarehouse in Florence, Kentucky.Source: Lovely Meds' regulations page.

S4PASSThe footer of every page states that compounded semaglutide and tirzepatide are not FDA-approved and have not been reviewed by the FDA, and each compounded product page repeats it. The semaglutide troche page says it contains the same active ingredient found in injectable and oral GLP-1 drugs.Source: Lovely Meds' website; Lovely Meds' compounded semaglutide page; Lovely Meds' semaglutide troche page; Lovely Meds' FAQ.

S5FAILNo certificate of analysis or lot document is published. The product pages describe pH, potency, endotoxin and sterility checks on each batch with no document behind the claim.Source: Lovely Meds' compounded semaglutide page; Lovely Meds' NAD+ page.

S6FAILTwo different addresses are printed for Lovely Meds, Inc.: the regulations page gives 5909 Perfect Calm Court, Clarksville, MD 21029 as the registered company address, and the privacy policy gives Suite 305, 131 Continental Dr, Newark, DE 19713 as its contact address. The terms name Delaware law.Source: Lovely Meds' regulations page; Lovely Meds' privacy policy; Lovely Meds' terms and conditions.

S7PASSCompounded semaglutide injections at $175 a month on a 1-month plan, $145 on 3 months, $120 on 6 months and $99 on 12 months, and compounded tirzepatide at $235, $199, $175 and $150, at the same price for every dose. A first month of $39 for semaglutide and $90 for tirzepatide is applied automatically at checkout, $60 below the from-price. Semaglutide ODT, oral drops and troche and tirzepatide oral drops from $209 a month, first month $149, and tirzepatide ODT from $289, first month $229. NAD+ from $115, first month $55, sermorelin injection from $99, first month $39, and sermorelin troche and nasal spray from $119, first month $59. No price is printed for the brand-name drugs.Source: Lovely Meds' compounded semaglutide page; Lovely Meds' compounded tirzepatide page; Lovely Meds' semaglutide page; Lovely Meds' tirzepatide page; Lovely Meds' oral semaglutide page; Lovely Meds' NAD+ page; Lovely Meds' compounded sermorelin page; Lovely Meds' sermorelin nasal spray page.

S8PASSFDA warning letter 716829, September 2025, names Lovely Meds, Inc. dba Lovely Meds at 5909 Perfect Calm Court, Clarksville, Maryland, the registered company address the site prints, and alleges that claims of the same active ingredient as Wegovy, Ozempic, Zepbound and Mounjaro were false or misleading for its compounded semaglutide and tirzepatide. No FDA action has halted the business, and the seller still trades.Source: FDA's website; FDA warning letter 716829.

Products shown on the seller's own pages at the recorded date: compounded semaglutide injection kit (with B12), compounded tirzepatide injection kit (with B12), compounded semaglutide oral drops, compounded tirzepatide oral drops, semaglutide ODT, tirzepatide ODT, semaglutide troche, microdosing semaglutide or tirzepatide, Zepbound, Mounjaro, Wegovy, Wegovy pill, Foundayo, Ozempic, NAD+ injection, nasal spray and face cream, sermorelin injection, sermorelin troche, sermorelin nasal spray, glutathione, MIC-B12, Lipo-C, hair foam with copper peptides, testosterone, enclomiphene and gonadorelin, sildenafil and tadalafil, finasteride and minoxidil, methylene blue, doxyPEP.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+Who sells glutathione

Enforcement documents on file: 1 warning letter

FDA warning letter 716829, issued September 2025, to Lovely Meds, Inc. dba Lovely MedsClaims that the compounded semaglutide and tirzepatide carry the same active ingredient as Wegovy, Ozempic, Zepbound and Mounjaro imply the products are the same as FDA-approved drugs, which the letter calls false or misleading.

A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.

Visit Lovely Meds

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.